Drug Shortage Report for IPRAVENT
Report ID | 186512 |
Drug Identification Number | 02246084 |
Brand name | IPRAVENT |
Common or Proper name | Ipravent |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 42MCG |
Dosage form(s) | SOLUTION |
Route of administration | NASAL NASAL |
Packaging size | 15ML |
ATC code | R01AX |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-03-23 |
Actual start date | |
Estimated end date | 2023-04-26 |
Actual end date | 2023-03-30 |
Shortage status | Resolved |
Updated date | 2023-03-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-03-08 | English | Compare |
v2 | 2023-03-08 | French | Compare |
v3 | 2023-03-22 | English | Compare |
v4 | 2023-03-22 | French | Compare |
v5 | 2023-03-24 | English | Compare |
v6 | 2023-03-30 | English | Compare |
v7 | 2023-03-30 | French | Compare |
v8 | 2023-03-31 | English | Compare |
Showing 1 to 8 of 8